Hypomagnesemia: A clinical perspective

International Journal of Nephrology and Renovascular Disease

Volumn 7, Issue , 2014, Pages 219-230

  Pham, Phuong Chi T ^a   Pham, Phuong Anh T ^b   Pham, Son V ^c   Pham, Phuong Truc T ^d   Pham, Phuong Mai T ^b   Pham, Phuong Thu T ^e  

^a OLIVE VIEW UCLA MEDICAL CENTER   (United States)

^b VETERANS AFFAIRS MEDICAL CENTER   (United States)

^c UNIVERSITY OF TEXAS HEALTH SCIENCE CENTER AT SAN ANTONIO   (United States)

^d PENNSYLVANIA STATE UNIVERSITY   (United States)

^e UNIVERSITY OF CALIFORNIA   (United States)

Author keywords

Alcohol; Cisplatin; Diabetes mellitus; Hypomagnesemia; Magnesium; TRPM6

Indexed keywords

AMIKACIN; AMINOGLYCOSIDE DERIVATIVE; AMPHOTERICIN; CALCINEURIN INHIBITOR; CETUXIMAB; CISPLATIN; CLAUDIN 16; CYCLOSPORIN; FOSCARNET; GENTAMICIN; INWARDLY RECTIFYING POTASSIUM CHANNEL; LOOP DIURETIC AGENT; MAGNESIUM; MAGNESIUM CHLORIDE; MAGNESIUM OXIDE; MAMMALIAN TARGET OF RAPAMYCIN INHIBITOR; PANITUMUMAB; PENTAMIDINE; POTASSIUM CHANNEL KV1.1; RAPAMYCIN; SODIUM CHLORIDE COTRANSPORTER; SODIUM POTASSIUM CHLORIDE COTRANSPORTER 2; TACROLIMUS; THIAZIDE DIURETIC AGENT; TRANSIENT RECEPTOR POTENTIAL CHANNEL M6; UNCLASSIFIED DRUG; URO MAG;

ABNORMAL URINE COMPOSITION; ACUTE PANCREATITIS; ALCOHOLISM; BARTTER SYNDROME; DIABETES MELLITUS; DIETARY INTAKE; DRUG SUBSTITUTION; DRUG WITHDRAWAL; GASTROINTESTINAL ABSORPTION; GITELMAN SYNDROME; GLOMERULUS FILTRATION; HENLE LOOP; HORMONAL REGULATION; HUMAN; HYPOCALCEMIA; HYPOMAGNESEMIA; KIDNEY DISTAL TUBULE; KIDNEY TUBULE ABSORPTION; LOSS OF FUNCTION MUTATION; MAGNESIUM EXCRETION; MAGNESIUM METABOLISM; MAGNESIURIA; MALABSORPTION; NEPHROTOXICITY; NONHUMAN; REVIEW;

EID: 84902207795     PISSN: None     EISSN: 11787058     Source Type: Journal    
DOI: 10.2147/IJNRD.S42054     Document Type: Review

References (83)

1. Sanders GT, Huijen HJ, Sanders R. Magnesium in disease: a review with special emphasis on the serum ionized magnesium. Clin Chem Lab Med. 1999;37(11-12):1011-1033.
2. Saris NE, Mervaala E, Karppanen H, Khawaja JA, Lewenstam A. Magnesium: an update on physiological, clinical and analytical aspects. Clin Chim Acta. 2000;294(1-2):1-26.
3. Swaminathan R. Magnesium metabolism and its disorders. Clin Biochem Rev. 2003;24(2):47-66.
4. Flink EB. Magnesium deficiency: etiology and clinical spectrum. Acta Med Scand Suppl. 1981;647:125-137.
5. Jahnen-Dechent W, Ketteler M. Magnesium basics. Clin Kidney J. 2012;5(Suppl 1):i3-i14.
6. Schwartz R, Spencer H, Welsh JJ. Magnesium absorption in human subjects from leafy vegetables, intrinsically labeled with stable 26 Mg. Am J Clin Nutr. 1984;39(4):571-576.
7. Fine KD, Santa Ana CA, Porter JL, Fordtran JS. Intestinal absorption of magnesium from food and supplements. J Clin Invest. 1991;88(2): 396-402.
8. Quamme GA. Recent developments in intestinal magnesium absorption. Cur Opin Gastroenterol. 2008;24(2):230-235.
9. Schweigel M, Martens H. Magnesium transport in the gastrointestinal tract. Front Biosci. 2000;5:D666-D677.
10. Schlingmann KP, Gudermann T. A critical role of TRPM channel-kinase for human magnesium transport. J Physiol. 2005;566(Pt 2):301-308.
11. Schlingmann KP, Weber S, Peters M, et al. Hypomagnesemia with secondary hypocalcemia is caused by mutations in TRPM6, a new member of the TRPM gene family. Nat Genet. 2002;31(2):166-170.
12. [no authors listed]. Plasma and bone magnesium. Nutrition Reviews. 1960;18(7):214-216.
13. Quamme GA, Dirks JH. The physiology of renal magnesium handling. Ren Physiol. 1986;9(5):257-269.
14. Quamme GA. Control of magnesium transport in the thick ascending limb. Am J Physiol. 1989;256(2 Pt 2):F197-F210.
15. Blanchard A, Jeunemaitre X, Coudol P, et al. Paracellin-1 is critical for magnesium and calcium reabsorption in the human thick ascending limb of Henle. Kidney Int. 2001;59(6):2206-2215.
16. Weber S, Schneider L, Peters M, et al. Novel paracellin-1 mutations in 25 families with familial hypomagnesemia with hypercalciuria and nephrocalcinosis. J Am Soc Nephrol. 2001;12(9):1872-1881.
17. Konrad M, Schaller A, Seelow D, et al. Mutations in the tight-junction gene claudin 19 (CLDN19) are associated with renal magnesium wasting, renal failure, and severe ocular involvement. Am J Hum Genet. 2006;79(5):949-957.
18. Hou J, Goodenough DA. Claudin-16 and claudin-19 function in the thick ascending limb. Curr Opin Nephrol Hypertens. 2010;19(5):483-488.
19. Voets T, Nilius B, Hoefs S, et al. TRPM6 forms the Mg2+ influx channel involved in intestinal and renal Mg2+ absorption. J Biol Chem. 2004;279(1):19-25.
20. Konrad M, Schlingmann KP, Guderman T. Insights into the molecular nature of magnesium homeostasis. Am J Physiol Renal Physiol. 2004;286(4):F599-F605.
21. Reily RF, Ellison DH. Mammalian distal tubule: physiology, pathophysiology, and molecular anatomy. Physiol Rev. 2000;80(1):277-313.
22. Lemmink HH, Knoers NV, Károlyi L, et al. Novel mutations in the thiazide-sensitive NaCl cotransporter gene in patients with Gitelman syndrome with predominant localization to the C-terminal domain. Kidney Int. 1998;54(3):720-730.
23. 2+ channel abundance explains thiazide-induced hypocalciuria and hypomagnesemia. J Clin Invest. 2005;115(6):1651-1658.
24. Yogi A, Callera GE, O'Connor SE, et al. Dysregulation of renal transient receptor potential melastatin 6/7 but not paracellin-1 in aldosterone-induced hypertension and kidney damage in a model of hereditary hypomagnesemia. J Hypertens. 2011;29(7):1400-1410.
25. Glaudemans B, van der Wijst J, Scola RH, et al. A missense mutation in the Kv1.1 voltage-gated potassium channel-encoding gene KCNA1 is linked to human autosomal dominant hypomagnesemia. J Clin Invest. 2009;119(4):936-942.
26. Groenestege WM, Thébault S, van der Wijst J, et al. Impaired basolateral sorting of pro-EGF causes isolated recessive renal hypomagnesemia. J Clin Invest. 2007;117(8):2260-2267.
27. Thebault S, Alexander RT, Tiel Groenestege WM, Hoenderop JG, Bindels RJ. EGF increases TRPM6 activity and surface expression. J Am Soc Nephrol. 2009;20(1):78-85.
28. Meij IC, Koenderink JB, van Bokhoven H, et al. Dominant isolated renal magnesium loss is caused by misrouting of the Na(+), (K+)-ATPase gamma-subunit. Nat Genet. 2000;26(3):265-266.
29. Arystarkhova E, Sweadner KJ. Splice variants of the gamma subunit (FXYD2) and their significance in regulation of the Na, K-ATPase in kidney. J Bioenerg Biomembr. 2005;37(6):381-386.
30. Ferrè S, Veenstra GJ, Bouwmeester R, Hoenderop JG, Bindels RJ. HNF-1B specifically regulates the transcription of the gamma a-subunit of the Na+/K+-ATPase. Biochem Biophys Res Commun. 2011;404(1): 284-290.
31. Kolatsi-Joannou M, Bingham C, Ellard S, et al. Hepatocyte nuclear factor-1 beta: a new kindred with renal cysts and diabetes and gene expression in normal human development. J Am Soc Nephrol. 2001; 12(10):2175-2180.
32. Scholl UI, Choi M, Liu T, et al. Seizures, sensorineural deafness, ataxia, mental retardation, and electrolyte imbalance (SeSAME syndrome) caused by mutations in KCNJ10. Proc Natl Acad Sci U S A. 2009;106(14):5842-5847.
33. Bockenhauer D, Feather S, Stanescu HC, et al. Epilepsy, ataxia, sensorineural deafness, tubulopathy, and KCNJ 10 mutations. N Engl J Med. 2009;360(19):1960-1970.
34. Paulais M, Bloch-Faure M, Picard N, et al. Renal phenotype in mice lacking the Kir5.1 (Kcnj16) K+ channel subunit contrasts with that observed in SeSame/EAST syndrome. Proc Natl Acad Sci U S A. 2011;108(25):10361-10366.
35. Cha SK, Huang C, Ding Y, Qi X, Huang CL, Miller RT. Calcium-sensing receptor decreases cell surface expression of the inwardly rectifying K+ channel Kir4.1. J Biol Chem. 2011;286(3):1828-1835.
36. Stuiver M, Lainez S, Will C, et al. CNNM2, encoding a basolateral protein required for renal Mg2+ handling, is mutated in dominant hypomagnesemia. Am J Hum Genet. 2011;88(3):333-343.
37. Song Y, Hsu YH, Niu T, Manson JE, Buring JE, Liu S. Common genetic variants of the ion channel transient receptor potential membrane melastatin 6 and 7 (TRPM6 and TRPM7), magnesium intake, and risk of type 2 diabetes in women. BMC Med Genet. 2009;10:4.
38. Groenestege WM, Hoenderop JG, van den Heuvel L, Knoers N, Bindels RJ. The epithelial Mg2+ channel transient receptor potential melastatin 6 is regulated by dietary Mg2+ content and estrogens. J Am Soc Nephrol. 2006;17(4):1035-1043.
39. Barr CS, Lang CC, Hanson J, Arnott M, Kennedy N, Struthers AD. Effects of adding spironolactone to an angiotensin-converting enzyme inhibitor in chronic congestive heart failure secondary to coronary artery disease. Am J Cardiol. 1995;76(17):1259-1265.
40. Gao X, Peng L, Adhikari CM, Lin J, Zuo Z. Spironolactone reduced arrhythmia and maintained magnesium homeostasis in patients with congestive heart failure. J Cardiac Fail. 2007;13(3):170-177.
41. Sontia B, Montezano AC, Paravicini T, Tabet F, Touyz RM. Downregulation of renal TRMP7 and increased inflammation and fibrosis in aldosterone-infused mice: effects of magnesium. Hypertension. 2008;51(4):915-921.
42. MacIntyre I, Robinson CJ. Magnesium and the gut: experimental and clinical observations. Ann N Y Acad Sci. 1969;162(2):865-873.
43. Hersh T, Siddiqui DA. Magnesium and the pancreas. Am J of Clin Nutr. 1973;26(3):362-366.
44. Agus ZS. Hypomagnesemia. J Am Soc Nephrol. 1999;10(7):1616-1622.
45. Elisaf M, Merkouropoulos M, Tsianos EV, Siamopoulos KC. Pathogenetic mechanisms of hypomagnesemia in alcoholic patients. J Trace Elem Med Biol. 1995;9(4):210-214.
46. Tambyah PA, Rauff A, Lee KO. Persistent hypomagnesaemia following parathyroid surgery, hypermagnesuria as a possible cause. Ann Acad Med Singapore. 1990;19(4):536-539.
47. Weiselberg EC, Gonzalez M, Fisher M. Eating disorders in the twenty-first century. Minerva Ginecol. 2011;63(6):531-545.
48. Frazier TG, Mucha ME, Rush IH, Trull EJ, Carlson SA, O'Connor JA. Hypomagnesemia: higher risk using total parenteral nutrition in the treatment of patients with malignancies. J Surg Oncol. 1980;13(1):35-38.
49. Flink EB. Magnesium deficiency. Etiology and clinical spectrum. Acta Med Scand Suppl. 1981;647:125-137.
50. Ho KM, Leonard A. Risk factors and outcome associated with hypomagnesemia in massive transfusion. Transfusion. 2011;51(2):270-276.
51. Aglio LS, Stanford GG, Maddi R, Boyd JL 3rd, Nussbaum S, Chernow B. Hypomagnesemia is common following cardiac surgery. J Cardiothorac Vasc Anesth. 1991;5(3):201-208.
52. Gearhart MO, Sorg TB. Foscarnet-induced severe hypomagnesemia and other electrolyte disorders. Ann Pharmacother. 1993;27(3):285-289.
53. Pham PCT, Pham PMT, Pham SV, Miller JM, Pham PTT. Hypomagnesemia in patients with type 2 diabetes. Clin J Am Soc Nephrol. 2007;2(2):366-373.
54. Shah GM, Alvarado P, Kirschenbaum MA. Symptomatic hypocalcemia and hypomagnesemia with renal magnesium wasting associated with pentamidine therapy in a patient with AIDS. Am J Med. 1990;89(3): 380-382.
55. Lee CT, Lien YHH, Lai LW, Ng HY, Chiou TT, Chen HC. Variations of dietary salt and fluid modulate calcium and magnesium transport in the renal distal tubule. Nephron Physiol. 2012;122(3-4):19-27.
56. Holmes AM, Hesling CM, Wilson TM. Drug-induced secondary hyperaldosteronism in patients with pulmonary tuberculosis. Q J Med. 1970;39(154):299-315.
57. Chou CL, Chen YH, Chau T, Lin SH. Acquired Bartter-like syndrome associated with gentamicin administration. Am J Med Sci. 2005;329(3): 144-149.
58. Zietse R, Zoutendijk R, Hoorn EJ. Fluid, electrolyte and acid-base disorders associated with antibiotic therapy. Nat Rev Nephrol. 2009;5(4):193-202.
59. Ledeganck KJ, Boulet GA, Horvath CA, et al. Effects of renal distal tubule transporters TRPM6 and NCC in a rat model of cyclosporine nephrotoxicity and effect of EGF treatment. Am J Physiol Renal Physiol. 2011;301(3):F486-F493.
60. Nijenhuis T, Hoenderop JG, Bindels RJ. Downregulation of Ca(2+) and Mg(2+) transport proteins in the kidney explains tacrolimus (FK506)-induced hypercalciuria and hypomagnesemia. J Am Soc Nephrol. 2004;15(3):549-557.
61. Ikari A, Okude C, Sawada H, Takahashi T, Sugatani J, Miwa M. Down-regulation of TRPM6-mediated magnesium influx by cyclosporin A. Naunyn Schmiedebergs Arch Pharmacol. 2008;377(4-6):333-343.
62. Aisa Y, Mori T, Nakazato T, et al. Effects of immunosuppressive agents on magnesium metabolism early after allogeneic hematopoietic stem cell transplantation. Transplantation. 2005;80(8):1046-1050.
63. Ikari A, Sanada A, Sawada H, Okude C, Tonegawa C, Sugatani J. Decrease in transient receptor potential melastatin 6 mRNA stability caused by rapamycin in renal tubular eptiherlial cells. Biochim Biophys Acta. 2011;1808(6):1502-1508.
64. da Silva CA, de Bragança AC, Shimizu MH, et al. Rosiglitazone prevents sirolimus-induced hypomagnesemia, hypokalemia, and downregulation of NKCC2 protein expression. Am J Physiol Renal Physiol. 2009;297(4):F916-F922.
65. Sánchez-Fructuoso AI, Santín Cantero JM, Pérez Flores I, Valero San Cecilio R, Calvo Romero N, Vilalta Casas R. Changes in magnesium and potassium homeostasis after conversion from a calcineurin inhibitor regimen to an mTOR inhibitor-based regimen. Transplant Proc. 2010;42(8):3047-3049.
66. Nijenhuis T, Renkema KY, Hoenderop JG, Bindels RJ. Acid-base status determines the renal expression of Ca2+ and Mg2+ transport proteins. J Am Soc Nephrol. 2006;17(3):617-626.
67. Zaika OL, Mamenko M, Palygin O, Boukelmoune N, Staruschenko A, Pochynyuk O. Direct inhibition of basolateral Kir4.1/5.1 and Kir4.1 channels in the cortical collecting duct by dopamine. Am J Physiol Renal Physiol. 2013;305(9):F1277-F1287.
68. Srivastava R, Aslam M, Kalluri SR, et al. Potassium channel KIR4.1 as an immune target in multiple sclerosis. N Engl J Med. 2012;367(2): 115-123.
69. Loffing J, Loffing-Cueni D, Hegyl I, et al. Thiazide treatment of rats provokes apoptosis in distal tubule cells. Kidney Int. 1996;50(4): 1180-1190.
70. Younes-Ibrahim M, Barnese M, Burth P, Castro-Faria MV. Inhibition of purified human kidney Na+-K+-ATPase by cyclosporine A: a possible mechanism for drug human nephrotoxicity. Ann N Y Acad Sci. 2003;986: 633-635.
71. Rodrigo R, Thielemann L. Effects of chronic and acute ethanol exposure on renal (Na+K)-ATPase in the rat. Gen Pharmacol. 1997;29(5): 719-723.
72. do Pazo-Oubiña F, Estefanell-Tejero A, Riu-Viladoms G, Anglada-Martínez H, Molas-Ferrer G, Creus-Baró N. Magnesium monitoring practice in monoclonal anti-epidermal growth factor receptor antibodies therapy. J Clin Pharma Ther. 2013;38(2):101-103.
73. Ledeganck KJ, Boulet GA, Bogers JJ, Verpooten GA, De Winter BY. The TRPM6/EGF pathway is downregulated in a rat model of cisplatin nephrotoxicity. PLoS One. 2013;8(2):e57016.
74. Chrispal A, Boorugu H, Prabhakar AT, Moses V. Amikacin-induced type 5 Bartter-like syndrome with severe hypocalcemia. J Postgrad Med. 2009;55(3):208-210.
75. Chou CL, Chen YH, Chau T, Lin SH. Acquired Bartter-like syndrome associated with gentamicin administration. Am J Med Sci. 2005;329(3): 144-149.
76. Rasmussen AQ, Jørgensen NR, Schwarz P. Clinical and biochemical outcomes of cinacalcet treatment of familial hypocalciuric hypercalcemia: a case series. J Med Case Rep. 2011;5(1):564.
77. Nair AV, Hocher B, Verkaart S, et al. Loss of insulin-induced activation of TRPM6 magnesium channels results in impaired glucose tolerance during pregnancy. Proc Natl Acad Sci U S A. 2012;109(28): 11324-11329.
78. Finkelstein A, Holz R. Aqueous pores created in thin lipid membranes by the polyene antibiotics nystatin and amphotericin B. Membranes. 1973;2:377-408.
79. Cunningham JJ, Anbar RD, Crawford JD. Hypomagnesemia: a multifactorial complication of treatment of patients with severe burn trauma. JPEN J Parenter Enteral Nutr. 1987;11(4):364-367.
80. Elisaf M, Panteli K, Theodorou J, Siamopoulos KC. Fractional excretion of magnesium in normal subjects and in patients with hypomagnesemia. Magnes Res. 1997;10(4):315-320.
81. Pham PC, Pham PM, Pham PA, et al. Lower serum magnesium levels are associated with more rapid decline of renal function in patients with diabetes mellitus type 2. Clin Nephrol. 2005;63(6):429-436.
82. Van Laecke S, Van Biesen W, Vanholder R. Hypomagnesaemia, the kidney and the vessels. Nephrol Dial Transplant. 2012;27(11):4003-4010.
83. US Department of Health and Human Services. National Institutes of Health. Magnesium fact sheet for health professionals. Available from ods. od. nih. gov/factsheets/Magnesium-HealthProfessional/#h3. Accessed March 27, 2014.